Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
US9700575B2 · kind B2 · utility
1Cited by
12References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2016 |
| Grant date | Jul 11, 2017 |
| Priority date | — |
| Expiry date | Jun 21, 2036 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D81/2069
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.